Navigation Links
Drug Helps Prevent Breast-Feeding Moms From Passing on HIV
Date:2/6/2008

6 weeks of nevirapine greatly reduced infant infections in Africa, India, study found

WEDNESDAY, Feb. 6 (HealthDay News) -- The antiretroviral drug nevirapine greatly reduces the risk that HIV-infected mothers will pass the virus to their babies during breast-feeding, according to a study conducted in Africa and India.

Nevirapine is already in widespread use in developing countries to prevent HIV-positive women from infecting their newborns during childbirth, note researchers at Johns Hopkins University, in Baltimore.

In this study, the Hopkins team and colleagues in Ethiopia, India and Uganda gave daily doses of the drug to breast-feeding infants when they were 8 to 42 days old.

By the time they reached 6 weeks of age, the rate of HIV infection among infants who received the drug daily was about half that of infants who received a single dose of nevirapine at birth, which is the current standard of care.

After six months, the infants who'd received the six-week drug treatment were almost a third less likely to suffer HIV infection or death than those given the single dose at birth.

The study included about 2,000 infants and was conducted from 2001 to 2007. It's one of the first randomized controlled trials to show that a drug can prevent HIV transmission in infants being breast-fed by HIV-infected mothers.

The findings were presented Monday at the Conference on Retroviruses and Opportunistic Infections, in Boston.

Breast-feeding is a major cause of HIV infection in the developing world. Each year, about 150,000 infants are infected with HIV through breast-feeding, according to the World Health Organization.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about HIV infections in infants and children.



-- Robert Preidt



SOURCE: Johns Hopkins Medicine, news release, Feb. 4, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. VMware Desktop Virtualization Helps Healthcare Providers Improve Patient Care
2. Kelloggs Frosted Flakes Gold(TM) Helps Moms Get the Gold
3. New strategy helps reduce errors in obstetrical care
4. Sex & the City Gets Serious About HIV and AIDS in South Africa - Kristin Davis Helps Oxfam Break the Stigma and Close the Treatment Gaps Fuelling AIDS
5. Arizona-Based Healthy Lifestyle Corporate Events Helps Football Fans Commit to Good Health
6. High-Dose Chemo Helps Beat Rare Brain Cancer
7. Anti-Clotting Drug Helps Infants With Heart Ills
8. In silico modeling helps predict severity of mitochondrial disease
9. Surprise in Lab Helps ID Drug to Fight ALS
10. Putting on Pedometer Helps Walkers Shed Pounds
11. Hormone Therapy Only Helps Some Older Men With Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Helps Prevent Breast-Feeding Moms From Passing on HIV
(Date:4/29/2016)... ... April 30, 2016 , ... World Patent Marketing ... Up Springboard, an automotive invention that improves the storage features of a pick ... billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Over ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... , announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula ... brain and mood optimization products to the store is just one more way ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House announced ... loans, more information about their loan terms and accounts, and more protections for ... including federal and private loans, has reached $1.3 trillion, with 43 million Americans ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton ... $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan Competition —as ... People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ making them ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering the many ... learn more about the options currently available to them and which ones might work ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... Oasmia Pharmaceutical AB (NASDAQ: ... new generation of drugs within human and veterinary ... Paclical/Apealea in the Phase III study that included ... cancer. These preliminary results showed non-inferiority between the ... versus Taxol in combination with carboplatin. In fact, ...
(Date:4/27/2016)... At the Sachs CEO forum ... Phase 2 clinical study of its lead drug candidate, ... implantation (CI) surgery. This large, placebo-controlled, double-blind, phase 2 ... and France . STR001 ... time of surgery. "Despite advances in cochlear implant technology, ...
(Date:4/26/2016)... April 26, 2016 US demand for ... expand 4.9 percent annually to $27.6 billion in ... facilities to decrease rates of healthcare-associated infections (HAIs) ... equipment, and services.  Although declining, the overall rate ... targeted levels set by the CDC.  Recent statistics ...
Breaking Medicine Technology: